Hepa-Merz

Ornithine aspartate, the active ingredient in Hepa-Merz, is a metabolic agent presented as an oral tablet for oral use. It is used to support liver function and may be employed as an adjunct in hepatic encephalopathy in adults.

GNH USA supplies Hepa-Merz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for global distribution.

Hepa-Merz (ornithine aspartate) is used in conditions related to impaired hepatic ammonia metabolism and general liver support.

- Hepatic encephalopathy: helps reduce blood ammonia levels and supports neurological function. - Chronic liver disease: contributes to maintenance of liver metabolic activity. - Alcohol‑related liver injury: assists in improving hepatic detoxification capacity.

Ornithine aspartate is generally well tolerated, but adverse reactions may occur.

Common Side Effects: - Nausea - Abdominal discomfort - Headache - Diarrhea

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) - Hepatic decompensation - Significant elevation of liver enzymes - Renal impairment

When considering Ornithine aspartate, several safety aspects should be reviewed.

- Pregnancy: consult a healthcare professional before use. - Renal impairment: use with caution and monitor renal function. - Hepatic impairment: assess liver status regularly. - Concomitant medications: review potential interactions with other ammonia‑lowering agents. - Alcohol consumption: limit intake as it may affect liver metabolism. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Ornithine aspartate may interact with certain medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Concurrent use with high‑dose ammonia scavengers (e.g., sodium benzoate): risk of excessive nitrogen load. - Combination with carbamyl phosphate synthetase inhibitors: may impair urea cycle function.

Moderate Interactions (Monitor Closely): - Diuretics (e.g., furosemide): monitor electrolyte balance and renal function. - Antibiotics altering gut flora (e.g., rifaximin): observe ammonia levels for possible additive effect. - Alcohol intake: may reduce efficacy and increase liver stress.